TZIELD DOSAGE AND ADMINISTRATION
TZIELD is administered by intravenous infusion (over a minimum of 30 minutes), using a body surface area–based dosing, once daily for 14 consecutive days.1
Once daily, consecutive 14-day course1
If a planned infusion is missed, resume course by administering all remaining doses on consecutive days to complete the 14-day course.
Do not administer 2 doses on the same day.
Administer TZIELD by IV infusion for a minimum of 30 minutes, using a body surface area–based dosing.
LABS PRIOR TO INITIATION
Prior to initiating TZIELD, obtain a complete blood count and liver enzyme tests. Use of TZIELD is not recommended in patients with certain laboratory abnormalities.1
Premedicate with: (1) a nonsteroidal anti-inflammatory drug (NSAID) or acetaminophen, (2) an antihistamine, and/or (3) an antiemetic before each TZIELD dose for at least the first 5 days of the 14-day treatment course.1